Academic Unit of Respiratory Medicine, University College London Medical School, Royal Free Campus, Rowland Hill Street, London, United Kingdom.
Am J Respir Crit Care Med. 2012 Jun 1;185(11):1218-24. doi: 10.1164/rccm.201110-1843OC. Epub 2012 Jan 26.
The Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) is an eight-item questionnaire designed to assess and quantify the impact of COPD symptoms on health status. COPD exacerbations impair quality of life and are characterized by worsening respiratory symptoms from the stable state. We hypothesized that CAT scores at exacerbation relate to exacerbation severity as measured by exacerbation duration, lung function impairment, and systemic inflammation.
To evaluate the usefulness of the CAT to assess exacerbation severity.
One hundred sixty-one patients enrolled in the London COPD cohort completed the CAT at baseline (stable state), exacerbation, and during recovery between April 2010 and June 2011.
Frequent exacerbators had significantly higher baseline CAT scores than infrequent exacerbators (19.5 ± 6.6 vs. 16.8 ± 8.0, P = 0.025). In 152 exacerbations, CAT scores rose from an average baseline value of 19.4 ± 6.8 to 24.1 ± 7.3 (P < 0.001) at exacerbation. Change in CAT score from baseline to exacerbation onset was significantly but weakly related to change in C-reactive protein (rho = 0.26, P = 0.008) but not to change in fibrinogen (rho = 0.09, P = 0.351) from baseline to exacerbation. At exacerbation, rises in CAT score were significantly associated with falls in FEV(1) (rho = -0.20, P = 0.032). Median recovery time as judged by symptom diary cards was significantly related to the time taken for the CAT score to return to baseline (rho = 0.42, P = 0.012).
The CAT provides a reliable score of exacerbation severity. Baseline CAT scores are elevated in frequent exacerbators. CAT scores increase at exacerbation and reflect severity as determined by lung function and exacerbation duration.
慢性阻塞性肺疾病(COPD)评估测试(CAT)是一个由八项问题组成的问卷,旨在评估和量化 COPD 症状对健康状况的影响。COPD 加重会降低生活质量,其特征是呼吸症状从稳定状态恶化。我们假设 CAT 评分在加重期与加重期的严重程度有关,这些严重程度可通过加重期持续时间、肺功能损害和全身炎症来衡量。
评估 CAT 评估加重严重程度的有效性。
2010 年 4 月至 2011 年 6 月,161 名患者参加了伦敦 COPD 队列研究,在基线(稳定状态)、加重期和恢复期完成 CAT 测试。
频繁加重患者的 CAT 评分明显高于非频繁加重患者(19.5 ± 6.6 比 16.8 ± 8.0,P = 0.025)。在 152 次加重中,CAT 评分从基线时的平均 19.4 ± 6.8 升高至 24.1 ± 7.3(P < 0.001)。从基线到加重开始时 CAT 评分的变化与 C 反应蛋白的变化显著相关,但较弱(rho = 0.26,P = 0.008),而与纤维蛋白原的变化不相关(rho = 0.09,P = 0.351)。在加重期,CAT 评分的升高与 FEV1 的下降显著相关(rho = -0.20,P = 0.032)。症状日记卡评估的中位恢复期与 CAT 评分恢复到基线所需的时间显著相关(rho = 0.42,P = 0.012)。
CAT 提供了一种可靠的加重严重程度评分方法。频繁加重患者的基线 CAT 评分升高。CAT 评分在加重期增加,反映了肺功能和加重期持续时间所决定的严重程度。